ACST logo

Acasti Pharma, Inc.


ACST: Acasti Pharma Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. Its novel drug delivery technologies have the potential to improve the performance of marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery all of which could help to increase treatment compliance and improve patient outcomes.


Show ACST Financials

Consumer Interest
SEC Filings

Recent trades of ACST by members of U.S. Congress

Recently reported changes by institutional investors

Quarterly net insider trading by ACST's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Apparatus for metering and dispensing viscous substance May. 10, 2022
  • Patent Title: Concentrated therapeutic phospholipid compositions Nov. 20, 2018
  • Patent Title: Concentrated therapeutic phospholipid compositions Oct. 25, 2016
  • Patent Title: Concentrated therapeutic phospholipid compositions Nov. 19, 2013
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ACST in WallStreetBets Daily Discussion


Recent insights relating to ACST

CNBC Recommendations

Recent picks made for ACST stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ACST

Corporate Flights

Flights by private jets registered to ACST